drugset / Trial / NCT07384429
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to explore the effects of the dual orexin receptor antagonist Lemborexant on improving motor and sleep comorbidity in patients with Parkinson's disease. This study will provide clinical evidence for the application of dual orexin receptor antagonists in the treatment of Parkinson's Disease.
Timeline
- Start
- 2026-08-19
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lemborexant | Small molecule | 5 mg | Oral |